LOSS OF HETEROZYGOSITY IN SPORADIC BREAST-TUMORS AT THE BRCA2 LOCUS ON CHROMOSOME 13Q12-Q13

被引：88

作者：

CLETONJANSEN, AM

COLLINS, N

LAKHANI, SR

WEISSENBACH, J

DEVILEE, P

CORNELISSE, CJ

STRATTON, MR

机构：

[1] INST CANC RES,SECT MOLEC CARCINOGENESIS,SUTTON SM2 5NG,SURREY,ENGLAND

[2] INST CANC RES,DEPT HISTOPATHOL,SUTTON SM2 5NG,SURREY,ENGLAND

[3] GENETHON,F-91002 EVRY,FRANCE

来源：

BRITISH JOURNAL OF CANCER | 1995年 / 72卷 / 05期

关键词：

BRCA2; RB1; LOSS OF HETEROZYGOSITY; BREAST CANCER; TUMOR-SUPPRESSOR GENE;

D O I：

10.1038/bjc.1995.493

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Loss of heterozygosity (LOH) on chromosome 13 occurs on 25-30% of breast tumours. This may reflect the inactivation of the retinoblastoma susceptibility gene RBI. However, recently another candidate tumour-suppressor gene has been identified on chromosome 13 by linkage analysis, the breast cancer susceptibility gene BRCA2. To investigate the involvement of BRCA2 in sporadic breast cancer 200 breast tumours were tested for LOH on chromosome band 13q12-q14, using 11 highly polymorphic microsatellite markers. LOH was found in 65 tumours, which all showed simultaneously loss of BRCA2 and RB1. Of 12 breast tumour cell Lines tested with polymorphic microsatellite markers, seven showed a contiguous region of homozygosity on 13q12-q14, suggesting LOH in the tumour from which the cell line had been derived. One cell line showed homozygosity in the BRCA2 region and heterozygosity at RBI. This is the only indication that BRCA2 is a distinct target for LOH on chromosome 13 in addition to RB1.

引用

页码：1241 / 1244

页数：4

共 14 条

[1] MOLECULAR-GENETIC ANALYSIS OF FLOW-SORTED OVARIAN TUMOR-CELLS - IMPROVED DETECTION OF LOSS OF HETEROZYGOSITY [J].

ABELN, ECA ;

CORVER, WE ;

KUIPERSDIJKSHOORN, NJ ;

FLEUREN, GJ ;

CORNELISSE, CJ .

BRITISH JOURNAL OF CANCER, 1994, 70 (02) :255-262

[2]

BORG A, 1992, CANCER RES, V52, P2991

[3]

COLLINS N, 1995, ONCOGENE, V10, P1673

[4] ALLELOTYPE OF HEAD AND NECK PARAGANGLIOMAS - ALLELIC IMBALANCE IS CONFINED TO THE LONG ARM OF CHROMOSOME-II, THE SITE OF THE PREDISPOSING LOCUS PGL [J].

DEVILEE, P ;

VANSCHOTHORST, EM ;

BARDOEL, AFJ ;

BONSING, B ;

KUIPERSDIJKSHOORN, N ;

JAMES, MR ;

FLEUREN, G ;

VANDERMEY, AGL ;

CORNELISSE, CJ .

GENES CHROMOSOMES & CANCER, 1994, 11 (02) :71-78

[5] RECENT DEVELOPMENTS IN THE MOLECULAR-GENETIC UNDERSTANDING OF BREAST-CANCER [J].

DEVILEE, P ;

SCHUURING, E ;

VANDEVIJVER, MJ ;

CORNELISSE, CJ .

CRITICAL REVIEWS IN ONCOGENESIS, 1994, 5 (2-3) :247-270

[6]

DODSON MK, 1994, CANCER RES, V54, P610

[7] THE 1993-94 GENETHON HUMAN GENETIC-LINKAGE MAP [J].

GYAPAY, G ;

MORISSETTE, J ;

VIGNAL, A ;

DIB, C ;

FIZAMES, C ;

MILLASSEAU, P ;

MARC, S ;

BERNARDI, G ;

LATHROP, M ;

WEISSENBACH, J .

NATURE GENETICS, 1994, 7 (02) :246-339

[8]

KIM TM, 1994, CANCER RES, V54, P605

[9] INACTIVATION OF THE RETINOBLASTOMA SUSCEPTIBILITY GENE IN HUMAN-BREAST CANCERS [J].

LEE, EYHP ;

TO, H ;

SHEW, JY ;

BOOKSTEIN, R ;

SCULLY, P ;

LEE, WH .

SCIENCE, 1988, 241 (4862) :218-221

[10] A STRONG CANDIDATE FOR THE BREAST AND OVARIAN-CANCER SUSCEPTIBILITY GENE BRCA1 [J].

MIKI, Y ;

SWENSEN, J ;

SHATTUCKEIDENS, D ;

FUTREAL, PA ;

HARSHMAN, K ;

TAVTIGIAN, S ;

LIU, QY ;

COCHRAN, C ;

BENNETT, LM ;

DING, W ;

BELL, R ;

ROSENTHAL, J ;

HUSSEY, C ;

TRAN, T ;

MCCLURE, M ;

FRYE, C ;

HATTIER, T ;

PHELPS, R ;

HAUGENSTRANO, A ;

KATCHER, H ;

YAKUMO, K ;

GHOLAMI, Z ;

SHAFFER, D ;

STONE, S ;

BAYER, S ;

WRAY, C ;

BOGDEN, R ;

DAYANANTH, P ;

WARD, J ;

TONIN, P ;

NAROD, S ;

BRISTOW, PK ;

NORRIS, FH ;

HELVERING, L ;

MORRISON, P ;

ROSTECK, P ;

LAI, M ;

BARRETT, JC ;

LEWIS, C ;

NEUHAUSEN, S ;

CANNONALBRIGHT, L ;

GOLDGAR, D ;

WISEMAN, R ;

KAMB, A ;

SKOLNICK, MH .

SCIENCE, 1994, 266 (5182) :66-71

← 1 2 →